How Has The Intracranial Stents Market Size Evolved In Recent Years?
The intracranial stents market has seen considerable growth due to a variety of factors.
• The market size of intracranial stents has seen a rapid expansion in recent times. The market is projected to balloon from $0.48 billion in 2024 to $0.55 billion in 2025, with a compound annual growth rate (CAGR) of 15.0%.
Factors contributing to this growth during the historic period include heightened awareness of the risks associated with stroke, enhanced patient education, implementation of greater safety measures concerning radiation, an aging population, and the advent of minimally invasive procedures.
What Are The Estimated Market Size And Expected Annual Growth Rates For Global Intracranial Stents Market?
The intracranial stents market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the intracranial stents market is likely to experience a significant expansion, with the expectation of reaching a market size of $1 billion by 2029, at an impressive compound annual growth rate (CAGR) of 16.3%.
The anticipated growth during this forecast period can be linked to several factors such as the advancement of telehealth services, embracing genomic medicine, improvements of healthcare facilities, expansion of stroke rehab services, and upward health initiatives. The forecast period also anticipates major trends like the adoption of bioresorbable intracranial stents, widespread use of neurointerventional robotics, incorporation of sophisticated imaging technologies, the acceptance of pediatric intracranial stents, and the plan of developing dual antiplatelet therapy strategies.
Which Drivers Are Accelerating Growth In The Intracranial Stents Market?
Growth in the intracranial stents market is forecasted to rise in the ensuing years due to the heightened occurrence of brain aneurysms. When there's a development of a lump in the blood vessels of the brain, it's identified as a brain aneurysm. This lump is at risk of breaking or bursting, resulting in a brain haemorrhage which could potentially lead to the patient's demise. Intracranial vessel stenting (IVS) represents a less intrusive method of addressing severe cerebral artery stenosis. This term describes the deteriorating condition of arteries supplying blood to the brain. Citing Medical News Today, a medical news portal from the UK, about 3.2% of people globally had unruptured aneurysms as of February 2023. Thus, the surge in brain aneurysm cases is the major factor propelling the growth of the intracranial stents market.
What Are The Core Segments Of The Global Intracranial Stents Market?
The intracranial stents market covered in this report is segmented –
1) By Type: Self Expanding Stents, Balloon Expanding Stents, Stent-Assisted Coil Embolization
2) By Disease Indication: Brain Aneurysm, Intracranial Stenosis
3) By End-User: Hospitals, Ambulatory Surgery Centers, Other End-Users
Subsegments:
1) By Self-Expanding Stents: Neurovascular Self-Expanding Stents, Biodegradable Self-Expanding Stents
2) By Balloon Expanding Stents: Drug-Eluting Balloon Expanding Stents, Bare Metal Balloon Expanding Stents
3) By Stent-Assisted Coil Embolization: Detachable Coil Systems, Non-Detachable Coil Systems
Pre-Book The Intracranial Stents Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Trends Are Reshaping The Intracranial Stents Market Size?
Key players in the intracranial stents market, such as Medtronic plc, an Ireland-based medical device company, are introducing innovative products like the Onyx Frontier drug-eluting stent (DES) to improve their market profitability. Onyx Frontier is a DES applied in the treatment of coronary artery disease (CAD), a condition caused by the buildup of plaque in the coronary arteries. Medtronic plc launched this stent in August 2022. The design of this stent makes it perfect for intricate percutaneous cardiac intervention (PCI) and offers high deliverability. The acute performance and medical data from the Resolute Onyx DES lay the groundwork for the Onyx Frontier DES, bringing an enhanced delivery method and superior acute performance.
Who Are the Key Players in the Intracranial Stents Market?
Major companies operating in the intracranial stents market include:
• Medtronic plc
• Balt Extrusion LLC.
• Stryker Corporation
• MicroPort Scientific Corporation
• Boston Scientific Corporation
• Acandis GmbH
• Admedes Schuessler GmbH
• MicroVention Inc.
• Phenox GmbH
• Terumo Corporation
• Johnson & Johnson Services Inc.
• Abbott Laboratories
• Brainlab AG
• Cardiatis SA
• Cook Medical LLC
• DePuy Synthes
• Endologix Inc.
• InspireMD Inc.
• Integra LifeSciences Corporation
• Kaneka Corporation
• Kerecis Limited
• Penumbra Inc.
• Rapid Medical Ltd.
• Vascular Solutions Inc.
• W. L. Gore & Associates Inc.
• Biotronik SE & Co. KG
• Cardionovum GmbH
• Codman Neuro
• C.R. Bard Inc.
• Cerebral Stents.
What are the Regional Insights into the Intracranial Stents Market?
North America was the largest region in the intracranial stents market in 2024. Asia-Pacific is expected to be the fastest region in the intracranial stents market share during the forecast period. The regions covered in the intracranial stents market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
